A Safety And Efficacy Study Of Alg-1001 In Human Subjects With Symptomatic Focal Vitreomacular Adhesion

Completed · Phase 2

Conditions studied: Symptomatic Focal Vitreomacular Adhesion

In brief

Evaluate the safety and efficacy of ophthalmic intravitreal injection of ALG-1001 in human subjects with symptomatic focal vitreomacular adhesion

Key facts

Study ID
NCT02153476
Run by
Allegro Ophthalmics, LLC
People needed
45
Starts
2014-02-01
Expected to finish
2015-06-01
Last updated by the study team
2018-12-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.